Reckitt Benckiser Group/£RKT
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Reckitt Benckiser Group
Reckitt Benckiser Group is a British multinational consumer goods company headquartered in Slough, England. It operates within the health, hygiene, and home product categories. The company's key brands include Dettol, Lysol, Durex, and Nurofen, offering a wide range of products from disinfectants to pharmaceuticals. Founded in 1999 through the merger of Reckitt & Colman and Benckiser, the company has a significant global presence, with operations in over 60 countries. Reckitt Benckiser's strategic strength lies in its diversified product portfolio and strong brand recognition, which facilitate its competitive positioning in various consumer markets.
Ticker
£RKT
Sector
Primary listing
LSE
Employees
37,900
Headquarters
Website
RKT Metrics
BasicAdvanced
£39B
31.60
£1.80
0.07
£1.22
2.14%
Price and volume
Market cap
£39B
Beta
0.07
52-week high
£58.30
52-week low
£44.86
Average daily volume
1.2M
Dividend rate
£1.22
Financial strength
Current ratio
0.556
Quick ratio
0.362
Long term debt to equity
101.922
Total debt to equity
148.11
Dividend payout ratio (TTM)
112.00%
Interest coverage (TTM)
8.03%
Profitability
EBITDA (TTM)
3,564
Gross margin (TTM)
60.89%
Net profit margin (TTM)
8.88%
Operating margin (TTM)
23.38%
Effective tax rate (TTM)
34.00%
Revenue per employee (TTM)
£370,000
Management effectiveness
Return on assets (TTM)
8.01%
Return on equity (TTM)
17.37%
Valuation
Price to earnings (TTM)
31.602
Price to revenue (TTM)
2.8
Price to book
6.13
Price to tangible book (TTM)
-3.72
Price to free cash flow (TTM)
19.419
Free cash flow yield (TTM)
5.15%
Free cash flow per share (TTM)
2.931
Dividend yield (TTM)
2.14%
Growth
Revenue change (TTM)
-2.41%
Earnings per share change (TTM)
-16.67%
3-year revenue growth (CAGR)
1.12%
10-year revenue growth (CAGR)
4.66%
3-year earnings per share growth (CAGR)
-24.88%
10-year earnings per share growth (CAGR)
-8.29%
3-year dividend per share growth (CAGR)
5.68%
10-year dividend per share growth (CAGR)
4.77%
What the Analysts think about RKT
Analyst ratings (Buy, Hold, Sell) for Reckitt Benckiser Group stock.
Bulls say / Bears say
Reckitt's main brands—Lysol, Dettol, and Strepsils—achieved 5.3% revenue growth in Q2, topping the forecasted 3.4%, which drove shares 9% higher and led to an upgrade of full-year core like-for-like net revenue guidance above 4%, overcoming currency challenges. (WSJ)
The company is leveraging strong growth in emerging markets, maintaining double-digit sales growth in China, and investing 300 million yuan ($40.9 million) in a new Shanghai R&D center to support local innovation. (Bloomberg)
Reckitt has launched a £1 billion share buyback and increased its interim dividend by 5% to 84.4 pence, reflecting robust free cash flow and reaffirming its commitment to returning value to shareholders. (MarketScreener)
Group net revenue for Q2 decreased 3.8% to £3.3 billion year-on-year, indicating overall sales are under pressure despite strong performance from core brands. (WSJ)
In Q4, Reckitt's Health segment delivered only 2.4% growth compared to the anticipated 6.9%, as a mild cold and flu season negatively impacted over-the-counter medicine sales. (Reuters)
Reckitt remains exposed to valuation risks on its Essential Home divestment, having received bids below expectations. This underperforming unit saw a 7% like-for-like sales drop in Q1, leading the company to consider alternative structuring for the deal. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2025.
RKT Financial Performance
Revenues and expenses
RKT Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
Sept18
Reckitt Benckiser Group
DividendPayment
£0.844Per share
FAQs
What’s the current market cap for Reckitt Benckiser Group stock?
Reckitt Benckiser Group (RKT) has a market cap of £39B as of September 17, 2025.
What is the P/E ratio for Reckitt Benckiser Group stock?
The price to earnings (P/E) ratio for Reckitt Benckiser Group (RKT) stock is 31.6 as of September 17, 2025.
Does Reckitt Benckiser Group stock pay dividends?
Yes, the Reckitt Benckiser Group (RKT) stock pays dividends to shareholders. As of September 17, 2025, the dividend rate is £1.217 and the yield is 2.14%. Reckitt Benckiser Group has a payout ratio of 112% on a trailing twelve-month basis.
When is the next Reckitt Benckiser Group dividend payment date?
The next Reckitt Benckiser Group (RKT) dividend payment is scheduled for September 18, 2025.
What is the beta indicator for Reckitt Benckiser Group?
Reckitt Benckiser Group (RKT) has a beta rating of 0.07. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.